US Patent 8362209 Telomerase reverse transcriptase variant

Patent 8362209 was granted and assigned to University of Medicine and Dentistry of New Jersey on January, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

University of Medicine and Dentistry of New Jersey

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8362209

Patent Inventor Names

Janine H. Santos0

Date of Patent

January 29, 2013

Patent Application Number

12733277

Date Filed

August 25, 2008

Patent Citations Received

‌

US Patent 11998595 Telomerase polypeptide vaccine for treating cancer

‌

US Patent 11905536 Anti-inflammatory peptides and composition comprising the same

Patent Primary Examiner

‌

Susan Hanley

Patent abstract

The present invention relates to nucleic and amino acid sequences of a novel variant of the telomerase reverse transcriptase. More particularly, the present invention is directed to a novel variant of human telomerase reverse transcriptase, which displays properties distinct from those of wildtype telomerase reverse transcriptase, and methods of use thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8362209 Telomerase reverse transcriptase variant

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API